Research study Program year 2021 Source: CMS Open Payments

Phase III RCC 1L Combo

Research payments

$2,330,129

100 payments

Through program year 2021, $2,330,129 in research payments was reported against Phase III RCC 1L Combo, across 100 payments.

Paid by (largest first)
E.R. Squibb & Sons, L.L.C.; Celgene Corporation
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2021 Research $415,990 27
2020 Research $1,465,210 39
2019 Research $448,930 34

Breakdown

Who paid Research payments · program years 2019–2021
  1. E.R. Squibb & Sons, L.L.C. $2,326,289 99 payments
  2. Celgene Corporation $3,840 1 payment
Who received the money Research payments · program years 2019–2021
  1. Sloan-Kettering Institute For Cancer Research Organisation paid for research $616,563 3 payments
  2. Emory University Hospital Teaching hospital · GA $186,328 2 payments
  3. Johns Hopkins University Organisation paid for research $158,594 3 payments
  4. Texas Oncology, P A Organisation paid for research $148,690 3 payments
  5. Beth Israel Deaconess Medical Center Teaching hospital · MA $146,602 6 payments
  6. Sarah Cannon Research Institute Organisation paid for research $133,395 3 payments
  7. Oregon Health & Sci University Organisation paid for research $96,482 1 payment
  8. American Oncologic Hospial Teaching hospital · PA $83,844 3 payments
  9. Ut Md Anderson Cancer Center Teaching hospital · TX $72,502 5 payments
  10. Carolinas Medical Center Teaching hospital · NC $63,833 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record